Design of ovalbumin-loaded mesoporous silica nanoparticles as proof of concept for the development of personalized anti-cancer nanovaccines

Despite the standard treatment, the prognosis of glioblastoma multiforme patients remains dismal. New therapies, like dendritic cell immunotherapy, are emerging to overcome the limitations of the current treatment. Multiple groups already use this treatment strategy and observe long term survival in several patients. Important disadvantages of this patient customized treatment are its high cost and limited...